Archive · 15 Jan 2026
Revanth to Launch Telangana Life Sciences Policy at Davos
The Chief Minister of Telangana, A. Revanth Reddy, is going to Davos, Switzerland, to launch a new policy for life sciences.
This policy aims to make Telangana one of the top three places in the world for life sciences by 2030.
The state wants to create a $250 billion life sciences economy.
They will showcase their plans for a Green Pharma City, Pharma Villages, and a special center called '1 Bio' for biopharma companies.
Telangana is already a big player in pharmaceuticals, making 40% of India's medicines and a third of the world's vaccines.
The launch at Davos will help them connect with global leaders and investors to promote their innovation ecosystem.
Chief Minister A. Revanth Reddy will launch the Telangana NextGen Life Sciences Policy 2026-30 at the World Economic Forum in Davos.
The policy aims to make Telangana one of the world's top three life sciences clusters by 2030 and build a $250 billion life sciences economy.
Key initiatives include the establishment of Green Pharma City, Pharma Villages, and '1 Bio', a biopharma scale-up facility in Genome Valley.
Telangana is already a major player in the pharmaceutical industry, contributing 40% of India's pharmaceutical production and hosting over 2,000 life sciences companies.
The Davos launch will serve as a platform to connect with global leaders, investors, researchers, and policymakers to promote high-value collaborations.
- Who
- Chief Minister A. Revanth Reddy and a delegation from Telangana
- What
- Launch of Telangana NextGen Life Sciences Policy 2026-30
- When
- January 19-23
- Where
- Davos, Switzerland
- Why
- To position Telangana as a global leader in life sciences and healthcare innovation
- Event
- Launch of Telangana NextGen Life Sciences Policy 2026-30
- Location
- Davos, Switzerland
- Date
- January 19-23
- Delegation Leader
- Chief Minister A. Revanth Reddy
- Policy Goal
- Position Telangana as a global leader in life sciences and healthcare innovation
- Key Initiatives
- Green Pharma City, Pharma Villages, '1 Bio' biopharma scale-up facility
- Economic Target
- $250 billion life sciences economy by 2030
- Current Contribution
- 40% of India's pharmaceutical production
